unknown
Stage
1
Investors
About
Dendrogenix is a Belgian biopharmaceutical company developing first-in-class small molecule drugs called Dendrogenins that stimulate cell differentiation and promote neuron and dendritic cell growth to address unmet medical needs in hearing loss and neurological diseases.
Explore DENDROGENIX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.